Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1993 Nov;52(11):785–789. doi: 10.1136/ard.52.11.785

Occurrence of antiperinuclear, antikeratin, and anti-RA 33 antibodies in juvenile chronic arthritis.

C Gabay 1, A M Prieur 1, O Meyer 1
PMCID: PMC1005189  PMID: 7504436

Abstract

OBJECTIVES--Antiperinuclear factor (APF), antikeratin antibodies (AKA), and anti-RA 33 antibodies are currently considered to be good markers for the diagnosis of adult rheumatoid arthritis with or without rheumatoid factor (RF). The prevalence of these markers was retrospectively reviewed in children with juvenile chronic arthritis (JCA) to determine whether they were associated with specific features. METHODS--One hundred and twenty-four patients with JCA participated in this study. Controls included 28 patients with juvenile systemic lupus erythematosus and 21 healthy children. Antiperinuclear factor and AKA were determined by indirect immunofluorescence on buccal mucosal cells and oesophagus sections respectively. Anti-RA 33 antibodies were detected using a Western blot technique on HeLa cell nuclear extract. RESULTS--Antiperinuclear factor was virtually absent in all the tested subgroups and anti-RA 33 antibodies were detected only in a subset of patients with RF positive polyarticular onset. Antikeratin antibodies were found in 27% of all children with JCA and in 42% of those with RF negative polyarticular onset. These results were statistically significant compared with healthy controls, but the presence of AKA was not specific to any patient subgroup. Moreover, in contrast with previous studies in adult RA, no relation was found between the presence of AKA and disease severity or activity. CONCLUSION--These data suggest that APF, AKA, and anti-RA 33 antibodies are not useful for the diagnosis or classification of JCA.

Full text

PDF
786

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ansell B. M. Heberden Oration, 1977. Chronic arthritis in childhood. Ann Rheum Dis. 1978 Apr;37(2):107–120. doi: 10.1136/ard.37.2.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  3. Feltkamp T. E., Berthelot J. M., Boerbooms A. M., Geertzen H. G., Hoet R., De Keyser F., van Venrooij W. J., Verbruggen G., Veys E. M., Youinou P. Interlaboratory variability of the antiperinuclear factor (APF) test for rheumatoid arthritis. Clin Exp Rheumatol. 1993 Jan-Feb;11(1):57–59. [PubMed] [Google Scholar]
  4. Hajiroussou V. J., Skingle J., Gillett A. P., Webley M. Significance of antikeratin antibodies in rheumatoid arthritis. J Rheumatol. 1985 Feb;12(1):57–59. [PubMed] [Google Scholar]
  5. Hassfeld W., Steiner G., Hartmuth K., Kolarz G., Scherak O., Graninger W., Thumb N., Smolen J. S. Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis. Arthritis Rheum. 1989 Dec;32(12):1515–1520. doi: 10.1002/anr.1780321204. [DOI] [PubMed] [Google Scholar]
  6. Hoet R. M., Boerbooms A. M., Arends M., Ruiter D. J., van Venrooij W. J. Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin. Ann Rheum Dis. 1991 Sep;50(9):611–618. doi: 10.1136/ard.50.9.611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Janssens X., Veys E. M., Verbruggen G., Declercq L. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis. J Rheumatol. 1988 Sep;15(9):1346–1350. [PubMed] [Google Scholar]
  8. Johnson G. D., Carvalho A., Holborow E. J., Goddard D. H., Russell G. Antiperinuclear factor and keratin antibodies in rheumatoid arthritis. Ann Rheum Dis. 1981 Jun;40(3):263–266. doi: 10.1136/ard.40.3.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kataaha P. K., Mortazavi-Milani S. M., Russell G., Holborow E. J. Anti-intermediate filament antibodies, antikeratin antibody, and antiperinuclear factor in rheumatoid arthritis and infectious mononucleosis. Ann Rheum Dis. 1985 Jul;44(7):446–449. doi: 10.1136/ard.44.7.446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kirstein H., Mathiesen F. K. Antikeratin antibodies in rheumatoid arthritis. Methods and clinical significance. Scand J Rheumatol. 1987;16(5):331–338. doi: 10.3109/03009748709102504. [DOI] [PubMed] [Google Scholar]
  11. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  12. Montecucco C., Caporali R., Negri C., de Gennaro F., Cerino A., Bestagno M., Cobianchi F., Astaldi-Ricotti G. C. Antibodies from patients with rheumatoid arthritis and systemic lupus erythematosus recognize different epitopes of a single heterogeneous nuclear RNP core protein. Possible role of cross-reacting antikeratin antibodies. Arthritis Rheum. 1990 Feb;33(2):180–186. doi: 10.1002/art.1780330205. [DOI] [PubMed] [Google Scholar]
  13. Moore T. L., Osborn T. G., Weiss T. D., Sheridan P. W., Eisenwinter R. K., Miller A. V., Dorner R. W., Zuckner J. Autoantibodies in juvenile arthritis. Semin Arthritis Rheum. 1984 May;13(4):329–336. doi: 10.1016/0049-0172(84)90013-1. [DOI] [PubMed] [Google Scholar]
  14. NIENHUIS R. L., MANDEMA E. A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR. Ann Rheum Dis. 1964 Jul;23:302–305. doi: 10.1136/ard.23.4.302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Nesher G., Moore T. L., Grisanti M. W., el-Najdawi E., Osborn T. G. Antiperinuclear factor in juvenile rheumatoid arthritis. Ann Rheum Dis. 1992 Mar;51(3):350–352. doi: 10.1136/ard.51.3.350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ordeig J., Guardia J. Diagnostic value of antikeratin antibodies in rheumatoid arthritis. J Rheumatol. 1984 Oct;11(5):602–604. [PubMed] [Google Scholar]
  18. Paimela L., Gripenberg M., Kurki P., Leirisalo-Repo M. Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid arthritis. Ann Rheum Dis. 1992 Jun;51(6):743–746. doi: 10.1136/ard.51.6.743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Quismorio F. P., Jr, Kaufman R. L., Beardmore T., Mongan E. S. Reactivity of serum antibodies to the keratin layer of rat esophagus in patients with rheumatoid arthritis. Arthritis Rheum. 1983 Apr;26(4):494–499. doi: 10.1002/art.1780260407. [DOI] [PubMed] [Google Scholar]
  20. Scott D. L., Delamere J. P., Jones L. J., Walton K. W. Significance of laminar antikeratin antibodies to rat oesophagus in rheumatoid arthritis. Ann Rheum Dis. 1981 Jun;40(3):267–271. doi: 10.1136/ard.40.3.267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sondag-Tschroots I. R., Aaij C., Smit J. W., Feltkamp T. E. The antiperinuclear factor. 1. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis. Ann Rheum Dis. 1979 Jun;38(3):248–251. doi: 10.1136/ard.38.3.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  23. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Veys E. M., De Keyser F., De Vlam K., Verbruggen G. The antiperinuclear factor. Clin Exp Rheumatol. 1990 Sep-Oct;8(5):429–431. [PubMed] [Google Scholar]
  25. Vincent C., Serre G., Lapeyre F., Fournié B., Ayrolles C., Fournié A., Soleilhavoup J. P. High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat oesophagus epithelium, so-called 'antikeratin antibodies'. Ann Rheum Dis. 1989 Sep;48(9):712–722. doi: 10.1136/ard.48.9.712. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Vivino F. B., Maul G. G. Histologic and electron microscopic characterization of the antiperinuclear factor antigen. Arthritis Rheum. 1990 Jul;33(7):960–969. doi: 10.1002/art.1780330707. [DOI] [PubMed] [Google Scholar]
  27. Westgeest A. A., Boerbooms A. M., Jongmans M., Vandenbroucke J. P., Vierwinden G., van de Putte L. B. Antiperinuclear factor: indicator of more severe disease in seronegative rheumatoid arthritis. J Rheumatol. 1987 Oct;14(5):893–897. [PubMed] [Google Scholar]
  28. Westgeest A. A., van Loon A. M., van der Logt J. T., van de Putte L. B., Boerbooms A. M. Antiperinuclear factor, a rheumatoid arthritis specific autoantibody: its relation to Epstein-Barr virus. J Rheumatol. 1989 May;16(5):626–630. [PubMed] [Google Scholar]
  29. Youinou P., Le Goff P., Colaco C. B., Thivolet J., Tater D., Viac J., Shipley M. Antikeratin antibodies in serum and synovial fluid show specificity for rheumatoid arthritis in a study of connective tissue diseases. Ann Rheum Dis. 1985 Jul;44(7):450–454. doi: 10.1136/ard.44.7.450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Youinou P., Le Goff P., Dumay A., Lelong A., Fauquert P., Jouquan J. The antiperinuclear factor. I. Clinical and serologic associations. Clin Exp Rheumatol. 1990 May-Jun;8(3):259–264. [PubMed] [Google Scholar]
  31. Youinou P., Pennec Y., Le Goff P., Ferec C., Morrow W. J., Le Menn G. Antiperinuclear factor in Sjögren's syndrome in the presence or absence of rheumatoid arthritis. Clin Exp Rheumatol. 1984 Jan-Mar;2(1):5–9. [PubMed] [Google Scholar]
  32. Youinou P., Seigneurin J. M., Le Goff P., Dumay A., Vicariot M., Lelong A. The antiperinuclear factor. II. Variability of the perinuclear antigen. Clin Exp Rheumatol. 1990 May-Jun;8(3):265–269. [PubMed] [Google Scholar]
  33. von Essen R., Ylijoki H., Savolainen A., Haapasaari J., Oksala U. M. Antiperinuclear factor in chronic juvenile arthritis. Ann Rheum Dis. 1992 Nov;51(11):1264–1264. doi: 10.1136/ard.51.11.1264-a. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES